Clinical Trial Update: Treatment of ARDS With Instilled T3 [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating intratracheal instillation of Triiodothyronine (T3) for acute respiratory distress syndrome (ARDS). The study is sponsored by the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Triiodothyronine (T3) (triiodothyronine)

Snippet

Sponsor: University of Minnesota | Conditions: ARDS, Human, Lung, Wet | Phase 2 | Status: ACTIVE_NOT_RECRUITING